Home About Us Contact Us
CMEweb.com
All CoursesCourses by TopicCourses by SpecialtyCourses by Specialty CreditRegister Now!!
Register Now!!
Member Login
Your Account
Your Test History
Your Certificates
Your Payment History
All Courses
Courses by Topic
Courses by Specialty
Courses by Specialty Credit
Accreditation
State Requirements
FAQs
 
Home : Advanced Search : Course view






Infectious Disease Alert (Vol. 36, No. 5) February 2017


Specialty: Infectious Diseases Format: Text 
Course #: 14002  Price: $54.00  
Release date: 2017-01-25  Valid through: 2020-02-28  
Publication: This activity appeared in Infectious Disease Alert, published on 2017-02-01. 
Review date: 2017-01-25 
Course viewing requirements  (opens in a new window)
Instructions for Course Participation  (opens in a new window)
Legal disclaimer  (opens in a new window)


Release date: February 2017

Valid through: February 2020

Target Audience

This activity is intended for the infectious disease specialist.

Subjects

  • Zika Virus and Risk of Congenital Abnormalities
  • Intrauterine Zika Virus Infection — Not Just Microcephaly at Birth
  • A Short Course of Antibiotics for Acute Otitis Media in Children Leads to Worse Outcomes Compared to Standard Course Therapy
  • Decreasing Malaria Mortality in Africa
  • Ventilator Associated Pneumonia with Minimal Ventilatory Requirements – Discontinuing Antibiotics after Three Days
  • Flu in Pregnancy: Increased Inflammation Demonstrated
  • Bezlotoxumab Injection (Zinplava)
  • Discharge Antibiotic Prescriptions Are Often Inappropriate with Regard to Choice, Dose, Duration

Objectives

  • Discuss the diagnosis of infectious diseases
  • Explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • Discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Credit Available

Physicians

  • Maximum of 3.0 AMA PRA Category 1 Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing

Authors

Stan Deresinski, MD, FACP, FIDSA, Clinical Professor of Medicine, Stanford University

Philip R. Fischer, MD, DTM&H, Professor of Pediatrics, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN

Dean Winslow, MD, Professor of Medicine, Division of General Medical Disciplines, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine

Richard R. Watkins, MD, MS, FACP, Division of Infectious Diseases, Akron General Medical Center, Akron, OH; Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH

Hal B. Jenson, MD, FAAP, Professor of Pediatric and Adolescent Medicine, Dean, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI

William Elliott, MD, FACP, Medical Director, Pharmacy, Northern California Kaiser Permanente, Assistant Professor of Medicine, University of California, San Francisco

James Chan, PharmD, PhD, Pharmacy Quality and Outcomes Manager, Kaiser Permanente, Oakland, CA.

Editors

Physician Editor:

Stan Deresinski, MD, FACP, FIDSA

Clinical Professor of Medicine,
Stanford University.

AHC Media Executive Editor: Shelly Morrow Mark

Financial Disclosure

Infectious Disease Alert’s editor, Stan Deresinski, MD, FACP, FIDSA, peer reviewer Patrick Joseph, MD, Updates author, Carol A. Kemper, MD, FACP, peer reviewer Kiran Gajurel, MD, senior accreditations officer Lee Landenberger, executive editor Shelly Morrow Mark, and assistant editor Jonathan Springston report no financial relationships to this field of study.

Dr. Richard Watkins reports that he has received research support from Allergan. Dr. Philip Fischer, Dr. Hal Jenson, Dr. Dean Winslow, William Elliott, MD, and James Chan, PharmD, report no financial relationships relevant to this field of study.

 

Copyright 2017, AHC Media. All rights reserved.



You are not currently logged in.
  • To view content articles and access course testing and evaluation, please login or register now